Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.25 and traded as low as $4.00. Evotec shares last traded at $4.04, with a volume of 48,150 shares trading hands.
Evotec Trading Down 1.5 %
The firm has a market capitalization of $1.33 billion, a P/E ratio of 9.85 and a beta of 0.98. The business’s 50 day moving average is $4.62 and its two-hundred day moving average is $4.25. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Recommended Stories
- Five stocks we like better than Evotec
- How to Evaluate a Stock Before Buying
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- The 3 Best Retail Stocks to Shop for in August
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is Forex and How Does it Work?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
